Minnesota Mining & Manufacturing Company v. International Biophysics Corporation

106 F.3d 426, 1997 U.S. App. LEXIS 27810, 1997 WL 12124
CourtCourt of Appeals for the Federal Circuit
DecidedJanuary 15, 1997
Docket96-1371
StatusUnpublished

This text of 106 F.3d 426 (Minnesota Mining & Manufacturing Company v. International Biophysics Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Minnesota Mining & Manufacturing Company v. International Biophysics Corporation, 106 F.3d 426, 1997 U.S. App. LEXIS 27810, 1997 WL 12124 (Fed. Cir. 1997).

Opinion

106 F.3d 426

NOTICE: Federal Circuit Local Rule 47.6(b) states that opinions and orders which are designated as not citable as precedent shall not be employed or cited as precedent. This does not preclude assertion of issues of claim preclusion, issue preclusion, judicial estoppel, law of the case or the like based on a decision of the Court rendered in a nonprecedential opinion or order.
MINNESOTA MINING & MANUFACTURING COMPANY, Plaintiff-Appellant,
v.
INTERNATIONAL BIOPHYSICS CORPORATION, Defendant-Appellee.

96-1371

United States Court of Appeals, Federal Circuit.

Jan. 15, 1997.

Before MICHEL, and CLEVENGER, Circuit Judge, and COWEN, Senior Circuit Judge,

CLEVENGER, Circuit Judge.

Minnesota Mining & Manufacturing (3M) appeals from an interlocutory order of the United States District Court for the Central District of California denying 3M's motion for a preliminary injunction to enjoin International Biophysics Corporation (IBC) from infringing U.S. Patent No. 4,786,474 (the '474 patent). The district court denied 3M's motion primarily on the ground that 3M failed to demonstrate likelihood of success on the infringement issue. Because the court erred on the infringement issue as a matter of law by failing properly to consider equivalents under § 112, para. 6 (§ 112(6)) and under the doctrine of equivalents for the sole limitation at issue, we vacate the order and remand.

* The patent in suit discloses a medical device for detecting various blood conditions during open-heart surgery. The device includes the following main components as shown in Fig. 1 of the '474 patent:

The diagram above shows a combination of a sensor unit 21 (top component) and a flow-through housing 13 (bottom component) for analyzing a patient's blood during the surgery. The sensor unit and the flow-through housing snap together, but are separated by semi-permeable membranes. The membranes are mounted on a membrane support unit 15 (middle component), which is bonded to the flow-through housing 13. During surgery, blood passes through the flow-through housing, allowing various constituents from the blood to diffuse through the membranes and into the sensors (not shown in the figure), which measure various characteristics of the blood (oxygen and carbon dioxide content and so forth).

Claim 1, the only claim in issue on this appeal, reads as follows (with emphasis added):

1. A membrane support apparatus with sensors comprising:

a housing having a flow passage for flow of liquid therethrough and means defining an opening leading to said flow passage;

a tensionable membrane permeable to a constituent of interest and impermeable to another constituent;

means for mounting the membrane on the housing with the membrane extending over the opening;

a sensor support, a section of the sensor support being extendible through the opening;

an optical sensor for sensing a characteristic of a first component of a liquid;

said optical sensor being carried by said section of the sensor support;

means for transmitting an optical signal form [sic, from] the optical sensor; and

means for mounting the sensor support on the housing with said section of the sensor support extending through the opening and with at least one of said section of the sensor support and said sensor engaging and tensioning the membrane.

The means limitation highlighted above is the only limitation in issue on this appeal. It relates to the manner in which the membranes are attached to the membrane support unit. This limitation is described more fully in conjunction with Fig. 3 of the patent:

As shown above, the means limitation in issue--means for mounting the membrane on the housing with the membrane extending over the opening--corresponds to a rectangular retaining bar 93 that the two membranes wrap around at the joint of the two membranes, and the so-wrapped bar is inserted in a groove 87 on the membrane support 15. This retaining bar structure may also be supplemented by adhesive. See '474 patent, col. 2, lines 52-53. Throughout the specification, it is emphasized that a strong attachment between the membranes and the membrane support is required for the invention, and that this strong attachment is provided by the retaining bar structure. See, e.g., '474 patent, col. 3, lines 25-29; col. 6, lines 17-21.

The comparable feature in IBC's accused flow-though housing is illustrated below:

In contrast to the retaining bar and the groove of the '474 patent, the IBC device mounts the membranes to the support 56 by adhesive and reinforces it by a figure 8 exterior frame 34. 3M also accuses IBC's single-membrane product, which is substantially similar to the two-membrane product depicted above, except the single-membrane product employs a rectangular exterior frame instead of the figure 8 frame used in the two-membrane embodiment.

II

The denial of a preliminary injunction is within the discretion of the district court and is reviewed on appeal under the abuse of discretion standard. Novo Nordisk of N. America, Inc. v. Genentech, Inc., 77 F.3d 1364, 1367, 37 USPQ2d 1773, 1775 (Fed.Cir.1996). An abuse of discretion may be established when the district court exercised its discretion based upon an error of law or clearly erroneous factual findings. Id.

As the moving party, 3M bears the burden of establishing its right to a preliminary injunction in light of four factors: (1) a reasonable likelihood of success on the merits, with respect to the patent's validity, enforceability, and infringement; (2) irreparable harm if the injunctive relief is not granted; (3) the balance of hardships favoring 3M; and (4) the impact of an injunction on the public interest. Id.; Reebok Int'l Ltd. v. J. Baker, Inc., 32 F.3d 1552, 1555, 31 USPQ2d 1781, 1783 (Fed.Cir.1994).

We have jurisdiction to review pursuant to 28 U.S.C. § 1292(c)(1) (1994).

III

The district court construed the means limitation in issue as "a means for mounting the membranes in which the membranes overlap each other, are wrapped partially around a retaining bar, and are wedged into a groove." The court noted:

The IBC device, on the other hand, does not appear to have a retaining bar, nor are the membranes wrapped around anything. Rather, the membranes are tensioned by a frame around their edges, to which they are bound by an adhesive material.

Thus, the district court found that the accused product lacks the retaining bar structure disclosed in the '474 patent specification. The district court then addressed the issues of equivalence under § 112(6) and under the doctrine of equivalents, but found insufficient showing of a likelihood of infringement.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
106 F.3d 426, 1997 U.S. App. LEXIS 27810, 1997 WL 12124, Counsel Stack Legal Research, https://law.counselstack.com/opinion/minnesota-mining-manufacturing-company-v-international-biophysics-cafc-1997.